Abstract:Background: Hepatic inflammatory and fibrotic lesions promote the development of cirrhosir and hepatocellular carcinoma in patients with chronic Hepatitis 8 (CHB). Farly recognition of hepatic histopathological changes and timely initiation of antivical therapy can delay or even reverse disease progression. Objectives: This study aimed to analyze non invasive diagnostic indicators associated inch different inflammation grades, fibrosis stages, and Hepatios degrees in CHB patients, and their outcomes after antiviral therapy Methods: A total of si CHB patients treated at the Third People's Hospital of Shenzhen from January December 2019 were selected for inflammation grading (G) and fibrous staging (5) based on liver puncture examination results. The patients were further dirnded into mild, moderate, and severe chronic Hepatitis groups. Correlation analysis was conducted via Spearman. The diagnostic performance of the relevant indexes for inflammation grading, bibrosi staging, and Hepatios degree grading was evaluated using receiver operator characteristics (ROC) The performance of different ROC curves was further compared using the DeLong rest. The effects of of antiviral drugs on patients with different liver hutopathological degrees were comparatively analyzed after 24, 48, 72, and 95 weeks. Results: Data analysis at baseline showed that 86.81% (79 of 91) of all patients were male. Additionally, about 61.54% (16 of 26), 30.77% (8 of 26), 85.19% (23 of 27), and 62.96% (17 of 27) of patients with normal ALT had G >= 2, G >= 3, S >= 2, and S >= 3, respectively inflammation grade, fibrosis stage, and Hepatitis degree were positively correlated with portal vein internal diameter, spleen thickness. LN, GPR, FIB-4, and 5 index, and negatively correlated with PLT (P<0.05). The area under the curve (AUC) of the ROC assessed multifactorial combinations PSUPTL, PSWPAHPCL, and PSWPHCL for predicting the risk of developing G3 inflammation, 5:3 fibrosis, and moderate to severe Hepatitis in patients with CHB were 0.806, 0.843, and 0.778, respectively. The diagnostic accuracies were higher than some of these factors applied indindually and some commonly used serological markers. HBV DNA levels were significantly lower in different Hepatitis groups after 24 werks of antiviral therapy than before treatment (P<0.05). Furthermore, the ALT normalization rate and HBV DNA clearance rate were slightly higher in the moderate and severe groups than in the mild group alter 48 werks of treatment (P>0.05). The serum liepatitis B envelope antigen (HBeAg) level was nguficantly lower in the severe group than in the mild group after 72 weeks of antiviral therapy (H7.043, P=0.030). Although only the HBeAg serologic conversion rate was significantly different at 96 weeks among the three groups (chi(2) = 12389,P=0.002), (BeAg negative and the serologic conversion rates higher in the severe group at each time point than in the mild and moderate groups Conclusions: Multiple non invasive indicators are strongly associated with different degrees of liver histopathology in patients with chronic HBV infection. Therefore, PSBPTL, PSWPAHPCI, and PSWPHCL can be used to predict the risk of developing Gas inflammation, 53 fibrosis, and moderate to severe Hepatitis in these pacients, respectively. Moreover, short term anuviral therapy has a more pronounced effect on patients with severe Hepatitis by improving hepatic inflammation and inhibiting viral replication.

Relali on between ultrasonography characteristics of gallbladder and G/S staging in chronic viral hepatitis

2005: Relation between indexes of spleen and G/S staging in chronic viral hepatitis

Relation Between Indexes of Portal Vein, Splenic Vein and G/S Staging in Chronic Viral Hepatitis

Value of Ultrasonography in Diagnosis of Xanthogranulomatous Cholecystitis

The Value of Ultrasonic Elastographic Parameters in the Evaluation of Chronic Hepatitis B Liver Fibrosis

Liver fibrosis in chronic viral hepatitis: an ultrasonographic study

Correlation Between Ultrasonographic and Pathologic Diagnosis of Liver Fibrosis Due to Chronic Virus Hepatitis.

Evaluation on the value of ultrasonic quantitative method in diagnosing liver fibrosis in chronic hepatitis B patients

Clinical Analysis of 50 Cases of Hepatic Veno-Occlusive Disease

Clinical application of contrast-enhanced ultrasonography in liver fibrosis

Grading and Staging of Hepatic Fibrosis, and Its Relationship with Noninvasive Diagnostic Parameters.

[Evaluation of the Value of Ultrasonography in Diagnosis of Liver Fibrosis in Patients with Chronic Viral Hepatitis].

Morphological Changes of Hepatic Parenchyma in Staging of Liver Fibrosis in Patients with Chronic Liver Diseases by High Frequency Ultrasound

Relationship Between Clinical and Pathologic Findings in Patients with Chronic Liver Diseases.

An analysis of the pathohistology of liver tissues, clinical features and prognostic factors of chronic hepatitis B virus carriers

Non-invasive Diagnostic Indicators and Antiviral Treatment Efficacy in CHB Patients with Different Liver Histopathological Degrees

Relationship Between Hepatic Histopathological Progression and Findings of Clinical Noninvasive Examination in Patients with Non-Viral Liver Diseases

A multi-institutional study on Ultrasound image analysis for staging HBV-derived liver fibrosis: a potential non-invasive alternative to liver stiffness measurement

Relationship between Pathological Grading and Staging of Chronic Liver Diseases and Serum Parameters

Noninvasive Assessment of Liver Fibrosis in Chronic HBV-infected Patients by Spleen Shear Wave Velocity Based on Virtual Touch Tissue Quantification Technique

[Noninvasive Evaluation of Liver Fibrosis in Chronic Hepatitis B Patients].